Genetic susceptibility to coronary heart disease in type 2 diabetes: 3 independent studies
- PMID: 22152955
- PMCID: PMC3240896
- DOI: 10.1016/j.jacc.2011.08.054
Genetic susceptibility to coronary heart disease in type 2 diabetes: 3 independent studies
Abstract
Objectives: The aim of this study was to evaluate whether coronary heart disease (CHD)-susceptibility loci identified by genome-wide association studies of the general population also contribute to CHD in type 2 diabetes.
Background: No study has examined the effects of these genetic variants on CHD in diabetic patients.
Methods: We genotyped 15 genetic markers of 12 loci in 3 studies of diabetic patients: the prospective Nurses' Health Study (309 CHD cases, and 544 control subjects) and Health Professional Follow-up Study (345 CHD cases, and 451 control subjects) and the cross-sectional Joslin Heart Study (422 CHD cases, and 435 control subjects).
Results: Five single-nucleotide polymorphisms, rs4977574 (CDKN2A/2B), rs12526453 (PHACTR1), rs646776 (CELSR2-PSRC1-SORT1), rs2259816 (HNF1A), and rs11206510 (PCSK9) showed directionally consistent associations with CHD in the 3 studies, with combined odds ratios (ORs) ranging from 1.17 to 1.25 (p = 0.03 to 0.0002). None of the other single-nucleotide polymorphisms reached significance in individual or combined analyses. A genetic risk score (GRS) was created by combining the risk alleles of the 5 significantly associated loci. The OR of CHD/GRS unit was 1.19 (95% confidence interval: 1.13 to 1.26; p < 0.0001). Individuals with GRS ≥8 (19% of diabetic subjects) had almost a 2-fold increase in CHD risk (OR: 1.94, 95% confidence interval: 1.60 to 2.35) as compared with individuals with GRS ≤5 (30% of diabetic subjects). Prediction of CHD was significantly improved (p < 0.001) when the GRS was added to a model including clinical predictors in the combined samples.
Conclusions: Our results illustrate the consistency and differences in the determinants of genetic susceptibility to CHD in diabetic patients and the general populations.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Figures

References
-
- Hunink MG, Goldman L, Tosteson AN, et al. The recent decline in mortality from coronary heart disease, 1980–1990. The effect of secular trends in risk factors and treatment. Jama. 1997;277:535–542. - PubMed
-
- Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. Jama. 2002;287:2570–2581. - PubMed
-
- Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–787. - PubMed
-
- Lusis AJ, Mar R, Pajukanta P. Genetics of atherosclerosis. Annu Rev Genomics Hum Genet. 2004;5:189–218. - PubMed
-
- Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007;316:1491–1493. - PubMed
Publication types
MeSH terms
Grants and funding
- HL34594/HL/NHLBI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- CA87969/CA/NCI NIH HHS/United States
- HL034594/HL/NHLBI NIH HHS/United States
- HL71981/HL/NHLBI NIH HHS/United States
- R01 HL034594/HL/NHLBI NIH HHS/United States
- U54 LM008748/LM/NLM NIH HHS/United States
- R01 HL071981/HL/NHLBI NIH HHS/United States
- DK46200/DK/NIDDK NIH HHS/United States
- DK36836/DK/NIDDK NIH HHS/United States
- P30 DK046200/DK/NIDDK NIH HHS/United States
- P30 DK036836/DK/NIDDK NIH HHS/United States
- R01 HL073168/HL/NHLBI NIH HHS/United States
- HL73168/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous